MGP
ABBV icon

Metis Global Partners’s AbbVie ABBV Stock Holding History

Metis Global Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Sell
82,938
-8,107
-9% -$1.74M 0.47% 36
2026
Q1 		$19.8M Sell
91,045
-2,937
-3% -$651K 0.49% 30
2025
Q4 		$21.5M Sell
93,982
-3,304
-3% -$753K 0.51% 27
2025
Q3 		$22.5M Sell
97,286
-4,727
-5% -$963K 0.53% 27
2025
Q2 		$18.9M Sell
102,013
-10,221
-9% -$1.9M 0.49% 31
2025
Q1 		$23.5M Buy
112,234
+13,570
+14% +$2.64M 0.66% 22
2024
Q4 		$17.5M Buy
98,664
+1,166
+1% +$214K 0.53% 28
2024
Q3 		$19.3M Buy
97,498
+2,172
+2% +$405K 0.6% 24
2024
Q2 		$16.4M Buy
95,326
+1,246
+1% +$206K 0.56% 26
2024
Q1 		$17.1M Sell
94,080
-825
-0.9% -$142K 0.62% 25
2023
Q4 		$14.7M Buy
94,905
+12,688
+15% +$1.85M 0.59% 27
2023
Q3 		$12.3M Buy
82,217
+11,382
+16% +$1.67M 0.59% 26
2023
Q2 		$9.54M Sell
70,835
-823
-1% -$121K 0.51% 27
2023
Q1 		$11.4M Buy
71,658
+18,008
+34% +$2.75M 0.73% 21
2022
Q4 		$8.67M Buy
53,650
+19,164
+56% +$2.94M 0.77% 22
2022
Q3 		$4.63M Sell
34,486
-306
-0.9% -$43.9K 0.75% 19
2022
Q2 		$5.33M Buy
34,792
+4,444
+15% +$679K 0.85% 17
2022
Q1 		$4.92M Buy
30,348
+12,539
+70% +$1.82M 0.59% 21
2021
Q4 		$2.41M Buy
+17,809
New +$2.1M 0.67% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Metis Global Partners's ABBV Position: Q2 2026 in Review

Metis Global Partners reduced its AbbVie (ABBV) stake by 8.9% in Q2 2026, selling an estimated $1.74M and leaving 82,938 shares worth $20.9M. The position accounts for 0.47% of the portfolio, ranked #36.

Metis Global Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $23.5M in Q1 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Metis Global Partners held 82,938 shares of AbbVie worth $20.9M as of Q2 2026.
  • Metis Global Partners sold 8,107 AbbVie shares in Q2 2026, an estimated $1.74M.
  • AbbVie made up 0.47% of Metis Global Partners's portfolio in Q2 2026, its #36 holding.
  • Metis Global Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's AbbVie position peaked at $23.5M in Q1 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.